Trial intelligence / Profile preview

Open-Label Safety Evaluation of the IONSYS System (Fentanyl) in Pediatric Postoperative Pain

2008-001173-14Phase 3Active

Sponsor
Janssen Pharmaceutical
Start
May 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of fentanyl in acute postoperative pain, sponsored by Janssen Pharmaceutical. Primary endpoint: Safety (respiratory and cardiovascular parameters). Started May 2008; status: active.

02

Drugs

fentanyl
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on 2008-001173-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001173-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call